Can a patient with pyelonephritis caused by a distal ureteric stone undergo ureteral stent placement?

Yes, a patient with pyelonephritis caused by a distal ureteric stone can and should undergo ureteral stent placement as the primary decompression method.

Ureteral stent placement has been shown to be safe and effective in the presence of obstructing ureteral stones and sepsis, with an overall decreased duration of hospital stay and intensive care unit admission rate compared with percutaneous nephrostomy (PCN) placement 1.

Clinical Approach Algorithm

Initial Management

When a patient presents with pyelonephritis from a distal ureteric stone:

1. Start broad-spectrum antibiotics immediately - antibiotics alone are insufficient without decompression 1
2. Proceed urgently to decompression - this is lifesaving in obstructive pyelonephritis 1
3. Choose retrograde ureteral stenting as first-line unless specific contraindications exist

Why Stenting is Preferred Over PCN

The evidence strongly supports retrograde ureteral stenting as the primary approach:

• Better outcomes: Shorter hospital stays and lower ICU admission rates 1
• Fewer subsequent interventions: PCN patients require significantly more follow-up procedures 1
• Definitive treatment pathway: Stented patients are more likely to receive ureteroscopic stone removal, while PCN patients typically require percutaneous approaches 1
• Technical success: While PCN has 100% technical success vs. 80% for retrograde stenting, the clinical benefits of stenting outweigh this difference 1

Important Caveats

Higher fever rates: Patients who receive stents experience a higher rate of documented fever compared to PCN 1. This is expected and manageable with appropriate antibiotics and monitoring.

Risk of urosepsis: In patients with extrinsic ureteral obstruction (not intrinsic stone obstruction), retrograde catheters may carry higher urosepsis risk 1. However, for distal ureteric stones causing intrinsic obstruction, this is not a primary concern.

When to Choose PCN Instead

PCN should be preferred in these specific situations:

• Pyonephrosis requiring larger tube decompression 1
• High anesthesia risk patients who cannot tolerate cystoscopy 1
• Failed retrograde stenting 1
• Unstable patients with multiple comorbidities 1

Timing Considerations

After initial stent placement for obstructive pyelonephritis:

• Proceed to definitive stone treatment within 7 days of fever resolution 2
• Keep stent in place ≤21 days before ureteroscopy to minimize post-operative febrile UTI risk 3
• Prolonging stent duration beyond 7 days provides no added benefit for infection control 2

Post-Stenting Monitoring

Monitor closely for:

• Worsening sepsis during and immediately after the procedure 1
• Fever (expected and more common than with PCN) 1
• Stent-related symptoms including irritative urinary symptoms and pain 4

Common Pitfalls to Avoid

1. Don't delay decompression: Time to decompression directly correlates with length of stay - every hour matters 5
2. Don't assume antibiotics alone will work: Decompression is mandatory 1
3. Don't avoid stenting due to fear of fever: The higher fever rate with stenting is manageable and doesn't translate to worse outcomes 1
4. Don't leave the stent in too long: Remove or proceed to definitive treatment within 21 days to minimize complications 3

Special Populations

Pregnancy: Retrograde ureteral stenting remains an attractive option with minimal fetal radiation exposure, though fluoroscopy is typically avoided and ultrasound guidance used instead 1

Septic shock: Even in severely septic patients, retrograde stenting can be performed safely and effectively 1, 5

The evidence consistently demonstrates that retrograde ureteral stenting is not contraindicated in pyelonephritis with obstructing stones - it is actually the preferred first-line approach for most patients, offering superior clinical outcomes despite a higher rate of transient fever 1.